PhageLab
PrivateLast Round
VC Round
Apr 10, 2026
Total Funding Raised
$44.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
PhageLab is a biotechnology company that develops tailor-made antibacterial solutions based on bacteriophages for the livestock and poultry industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PhageLab Comparables
Compare PhageLab with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phagos | 82% | |
| Proteon Pharmaceuticals | 82% | |
| Cytophage Technologies | 77% |
PhageLab Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 10, 2026 | ||||
| Convertible Debt | Dec 11, 2025 | ||||
| Series A | Jan 23, 2024 | ||||
| Series A | Oct 5, 2021 |
PhageLab Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nazca | Series A |
| Humboldt Fund | Series A |
| Collaborative Fund | Series A |
| Waterlemon | Series A |
| The Yield Lab | Convertible Debt |
| Kaszek | Series A, Convertible Debt, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 10, 2026
$3M round led by Kaszek.
- Dec 11, 2025
$4M round led by Kaszek
PhageLab Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PhageLab's valuation, stock price, and market status.
Is PhageLab a public or private company?
PhageLab is a private company.
What is the current stock price of PhageLab?
PhageLab is a private company, so its shares have no public market price. Caplight tracks PhageLab's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PhageLab worth (valuation)?
Valuation information for PhageLab is not publicly available.
Can I buy PhageLab stock?
PhageLab shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PhageLab's last funding round?
PhageLab's most recent funding round was VC Round on April 10, 2026.
Who are the main investors in PhageLab?
Key investors in PhageLab include Kaszek.
Will PhageLab IPO soon?
No public IPO plans have been announced for PhageLab.
How can I track PhageLab secondary market activity?
Caplight tracks bids, offers, and trades in PhageLab's shares on secondary markets.